Tissue Regenix Group plc
Company Profile
Company website
Sector
Pharmaceuticals & Biotechnology (Biotechnology)
Description
Tissue Regenix is a leading medical devices company in the field of regenerative medicine. The company's patented decellularisation ('dCELL®') technology removes DNA and other cellular material from animal and human soft tissue leaving an acellular tissue scaffold which is not rejected by the patient's body and can then be used to repair diseased or worn out body parts. Current applications address many critical clinical needs such as sports medicine, heart valve replacement and wound care.
Not all Walbrook clients have a Company Presentation available. Click on "Register your interest" and we'll let the Company know that you think this would be useful
Latest Company

Latest Company
Presentation
Not all Walbrook clients have a handy 2 page summary available. Click on "Register your interest" and we'll let the Company know that you think this would be useful

Latest Company Summary
Investor Access Events
There is no Investor Access event planned at the moment - click on "Register your Interest" and we'll tell the Company that you'd like to attend one in the future and update you when an event is planned.